SynthesisJournal of translational medicine2025
Association between 25-hydroxy vitamin D levels and risk of frailty and pre-frailty in elderly adults: a systematic review and dose-response meta-analysis of epidemiologic studies with GRADE assessment.
Synthesis in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Vitamin D Deficiency Is Associated with Greater Sarcopenia-Related Risk Severity and Functional Decline in Older Adults: A Retrospective Cross-Sectional Study.Medicina (Kaunas, Lithuania) · 2026Article
- Network Analysis of Food Intake Patterns and Frailty Dimensions in Chinese Older Adults: A National Cross-Sectional Study.Nutrients · 2026Article
- Vitamin D Deficiency in Institutionalized Older Adults: Associations with Supplementation Practices but Not with Cognitive Decline or Dementia.Nutrients · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA growing number of studies investigated vitamin D and frailty have led to conflicting results. This systematic review and meta-analysis aimed to summarize and update the current evidence surrounding the association between vitamin D and risk of frailty and pre-frailty in elderly adults.
methodsMEDLINE (PubMed), Scopus, Institute for Scientific Information (ISI) Web of Science databases, and Google Scholar were searched for all published articles up to January 2025. All observational studies that reported odds ratios (ORs) or relative risks (RRs) with 95% confidence intervals (CIs) for the association between 25-hydroxy vitamin D (as independent variable) and frailty (as dependent variable) were included. Maximally adjusted effect sizes were pooled. Certainty of evidence was assessed by the GRADE approach.
resultsA total of 41 studies (6 cohorts, 31 cross-sectionals and 4 studies with information of baseline and longitudinal) were included. Highest (vs. lowest) level of vitamin D in prospective cohort studies (with 14,153 participants and 2,137 cases with frailty) was significantly related to a 29% reduction in risk of frailty (pooled RR: 0.71; 95% CI: 0.60, 0.84). Also, a significant inverse association was found in cross-sectional studies with 42,936 cases out of 500,826 participants (OR: 0.50; 95% CI: 0.44, 0.56). Based on linear dose-response analysis, each 10 ng/mL (or 25 nmol/L) increase in serum vitamin D level was inversely related to risk of frailty in cohort (RR: 0.83; 95% CI: 0.77, 0.91) and cross-sectional (OR: 0.73; 95%CI: 0.66, 0.81) studies. Also, non-linear dose-response analysis on eligible studies was significant in both cross-sectional and cohort studies (P
conclusionThis systematic review and meta-analysis documented inverse associations between vitamin D and frailty, as well as prefrailty, and supported vitamin D as a potential cost-effective screening tool for identifying individuals at risk of frailty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.